Shortage of COBAL-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.

Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of COBAL-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule AUST R: 285067 in Australia.

The Australian registered medicine, COBAL-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule

AUST R: 285067, Solution Sponsor: Amdipharm Mercury Australia Pty Ltd is currently in shortage due to manufacturing issues.

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, VITARUBIN Depot hydroxocobalamin acetate 1mg/mL (Streuli Pharma, Switzerland). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 30th March 2024.

Other brands of this product in Australia include NEO-B12 INJECTION Hydroxocobalamin 1000 microgram/1 mL injection ampoule, VITA-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule, HYDROXO-B12 hydroxocobalamin chloride 1mg/1mL injection ampoule

For orders, please email it to orders@propg.com.au

VITARUBIN Depot hydroxocobalamin acetate 1mg/mL (Streuli Pharma, Switzerland)